AGTR1 and metabolic dysfunction-associated steatotic liver disease: Particularly notable results of the in vitro experiments were that aspirin lowered the level of AT1R in both HUVEC and HepG2 cells; therefore, aspirin may simultaneously affect atherosclerosis and NAFLD.